Bradley Hasson MBA Merck KGaA

Bradley Hasson is the Director of Lab Operations for Next Generation Sequencing Services at Merck KGaA. Brad leads a global team of Scientists, laboratory technicians and bioinformaticians that perform NGS-based testing services in support of product characterization, adventitious agent detection and product release for biologically derived products worldwide. He has over 20 years of industry experience, including 16 years developing, validating and commercializing molecular-based methods for the purposes of biosafety testing and characterization in a variety of biologically derived products.